FDA Events Calendar

Track upcoming clinical trials, regulatory milestones, and biotech events

October 2026

271 events

Sun

Mon

Tue

Wed

Thu

Fri

Sat

1

EVO301 Rezpegaldesleukin (LY3471851) - (REZOLVE-AA)Trevogrumab, semaglutide with and without garetosmab - (COURAGE)

2

Ecopipam (EBS-101) - (D1AMOND)Jaypirca (pirtobrutinib) - (BRUIN CLL-313)Mim8 - (FRONTIER5)

3

4

WELIREG (belzutifan) and LENVIMA (lenvatinib) - (LITESPARK-011)

5

VAX-31 - (OPUS-1)Cadisegliatin - (CATT1)RAD101

6

OST-HER2 (AOST-2121)CB-011 - (CaMMouflage)STK-002 - (OSPREY)

7

RP-A501 Ateganosine (THIO-101)Epioxa - (GLK-202-03)

8

KERENDIA (finerenone) - (FIND-CKD)VIR-5500 FB102 - (FB102-301)

9

envudeucitinib (ESK-001) - (ONWARD3)VOXZOGO (Vosoritide)ASC40 (denifanstat) - (AURORA)

10

Obexelimab - (INDIGO)Tarcocimab tedromer (KSI-301) - (GLOW2)SAB-142 - (SAFEGUARD)

11

12

Efzimfotase alfa (ALXN1850) - (HICKORY)Aficamten - (ACACIA-HCM)SIMPONI (golimumab) - (GALAXI)

13

EB613 BMF-650 (GLP-131)KO-7246

14

VQW-765 - (Study 3201)ANKTIVA (nogapendekin alfa inbakicept-pmln) in combination with Bacillus Calmette-Guerin (BCG)VK2735 (SUNRISE-2)

15

IMC-S118AI REC-4881 - (TUPELO)QTORIN - (TOIVA)

16

IV choline chloride - (THRIVE-3)

17

Leniolisib SL-846 MR-141 (phentolamine ophthalmic solution 0.75%) - (VEGA-2/VEGA-3)

18

Bezisterim (NE3107) - (ADDRESS-LC)PALI-2108 - (ASCENTRA-CD)

19

ozekibart (INBRX-109)Bezisterim (NE3107) - (SUNRISE-PD)SL-846

20

Nalbuphine ER - (CORAL)OD-07656 Zervimesine (CT1812) - (SHIMMER)

21

TNX-801 - (Kenya study)Miv-cel (mivocabtagene autoleucel, KYV-101) - (KYSA-8)Vidofludimus Calcium (IMU-838) - (CALLIPER)

22

zelicapavir (EDP-938) (RSVP)ATEV - (V007)ABCL635

23

Vafseo (vadadustat)(TIW) versus an erythropoiesis-stimulating agent (ESA). - (VOICE)[212Pb]VMT-α-NET Tegoprubart (AT-1501) - (BESTOW)

24

Budoprutug (TNT119) - (PrisMN)MZE829 - (HORIZON)Tovecimig (CTX-009 (DLL4 X VEGF-A bispecific)) - (COMPANION-002)

25

hexavalent OX40 agonist ordastobart (INBRX-106) with Keytruda (pembrolizumab)- (HexAgon-HN)Givastomig (CLDN18.2 x 4-1BB bispecific antibody)Leronlimab with trifluridine plus tipiracil (TAS-102) and bevacizumab - (CLOVER)

26

ZL 1310 (DLL3 ADC) plus Atezolizumab ± Carboplatin - (ZL 1310-001)ORPATHYS (savolitinib) and TAGRISSO (osimertinib) - (SANOVO)intismeran autogene - (INTerpath-014)

27

BB-301 EVX-01 + KEYTRUDA (pembrolizumab) / OPDIVO (nivolumab)

28

CHS-114 (Tagmokitug) in Combination With Toripalimab BEAM-301

29

ozekibart (INBRX-109)

30

INO-3107 INO-3107

31

VAX-31 - (OPUS-1)micvotabart pelidotin (PYX-201-101) - (MICVO)VS-7375 - (TARGET-D 101)

Clinical Read

Regulatory

Meetings & Presentations